Song H H, Shi W, Filmus J
Department of Medical Biophysics, University of Toronto, Toronto, Ontario M4N 3M5, Canada.
J Biol Chem. 1997 Mar 21;272(12):7574-7. doi: 10.1074/jbc.272.12.7574.
OCI-5 encodes the rat homologue of glypican-3, a membrane-bound heparan sulfate proteoglycan that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome. OCI-5 and glypican-3 are 95% identical. It has been recently suggested that glypican-3 interacts with insulin-like growth factor-2 (IGF-2) and that this interaction regulates IGF-2 activity. We report here that we have transfected OCI-5 into two different cell lines, and we have not been able to detect an interaction between the OCI-5 proteoglycan produced by the transfected cells and IGF-2. On the other hand, we have found that OCI-5 interacts with FGF-2, as has already been shown for glypican-1. This interaction is mediated by the heparan sulfate chains of OCI-5 because it can be inhibited by heparin or by heparitinase.
OCI-5编码glypican-3的大鼠同源物,glypican-3是一种膜结合硫酸乙酰肝素蛋白聚糖,在辛普森-戈拉比-贝梅尔过度生长综合征中发生突变。OCI-5与glypican-3的同源性为95%。最近有研究表明,glypican-3与胰岛素样生长因子-2(IGF-2)相互作用,且这种相互作用调节IGF-2的活性。我们在此报告,我们已将OCI-5转染到两种不同的细胞系中,但未能检测到转染细胞产生的OCI-5蛋白聚糖与IGF-2之间存在相互作用。另一方面,我们发现OCI-5与FGF-2相互作用,这与glypican-1的情况相同。这种相互作用由OCI-5的硫酸乙酰肝素链介导,因为它可被肝素或肝素酶抑制。